Xianlian Jiedu Prescription Suppresses Colorectal Cancer EMT by Blocking Tumor-associated Macrophage-derived CCL5 Secretion and Inhibiting STAT3/β-catenin Signaling Pathway
|更新时间:2025-09-08
|
Xianlian Jiedu Prescription Suppresses Colorectal Cancer EMT by Blocking Tumor-associated Macrophage-derived CCL5 Secretion and Inhibiting STAT3/β-catenin Signaling Pathway
“The latest research has found that Xianlian Jiedu Formula can effectively inhibit the metastasis of colorectal cancer, and its mechanism may involve targeting CCL5 derived from tumor associated macrophages and inhibiting the imbalance of EMT marker expression mediated by STAT3 phosphorylation.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 19, Pages: 138-147(2025)
QIAN Jingyang,TAO Lihuiping,ZHANG Qinchang,et al.Xianlian Jiedu Prescription Suppresses Colorectal Cancer EMT by Blocking Tumor-associated Macrophage-derived CCL5 Secretion and Inhibiting STAT3/β-catenin Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(19):138-147.
QIAN Jingyang,TAO Lihuiping,ZHANG Qinchang,et al.Xianlian Jiedu Prescription Suppresses Colorectal Cancer EMT by Blocking Tumor-associated Macrophage-derived CCL5 Secretion and Inhibiting STAT3/β-catenin Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(19):138-147. DOI: 10.13422/j.cnki.syfjx.20251324.
Xianlian Jiedu Prescription Suppresses Colorectal Cancer EMT by Blocking Tumor-associated Macrophage-derived CCL5 Secretion and Inhibiting STAT3/β-catenin Signaling Pathway
Effect of Xianlian Jiedu Prescription Regulating Intestinal Flora and CD8+ T Cell Immune Response on Colorectal Cancer
Efficacy Mechanism of Xianlian Jiedu Prescription Against Colorectal Cancer Recurrence vias Regulating Angiogenesis
Effect and Mechanism of Xianlian Jiedu Prescription Against Proliferation of Colorectal Cancer Cells in Hypoxic Microenvironment
Related Author
ZHUANG Yupei
ZHOU Hongli
LIANG Yuwei
ZHENG Mingyue
YUAN Weichen
CHENG Haibo
ZHOU Hongguang
XU Yanru
Related Institution
Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, The First Clinical College, Nanjing University of Chinese Medicine
College of Pharmacy, Nanjing University of Chinese Medicine
The First Clinical College of Nanjing University of Chinese Medicine
School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine
The Affiliated Hospital of Nanjing University of Chinese Medicine